Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000778540 | SCV000914829 | uncertain significance | Polycystic liver disease 1 | 2017-10-18 | criteria provided, single submitter | clinical testing | The PRKCSH c.-77-2A>C variant occurs in a canonical splice site (acceptor) and is therefore predicted to disrupt or distort the normal gene product. The c.-77-2A>C variant has been reported in one study and found in one individual in a heterozygous state (Johnston et al. 2015). However, this individual was not affected with polycystic kidney disease. The variant is reported at a frequency of 0.000067 in the European (non-Finnish) population of the Genome Aggregation Database, but this is based on one allele only in a region of good sequence coverage so the variant is presumed to be rare. Based on the potential impact of splice acceptor variants and the lack of clarifying evidence, this variant is classified as a variant of unknown significance but suspicious for pathogenicity for polycystic liver disease. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. |
Fulgent Genetics, |
RCV000778540 | SCV002776658 | uncertain significance | Polycystic liver disease 1 | 2022-03-04 | criteria provided, single submitter | clinical testing |